| While the Swedish healthcare system has established measures against inequitable treatment access, geographical differences in the prescription of biologics were present after adjusting for patient characteristics and disease severity. |
| Over time, regional differences did not disappear, nor decrease in magnitude, though the national switch rate to biologics was stable at approximately 10%. |
| Evidence of persistent regional differences in access to biologics motivates similar investigations in other countries. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.